SCHEMBL5355490

SCHEMBL5355490

OC(C1CCC(N(Cc2ccccc2)CC2CC2)CC1)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.44
SLC6A4 P31645 4/20 0.44
LTA4H P09960 1/20 0.39
NR1H2 P55055 4/20 0.39
NR1H3 Q13133 4/20 0.39
YTHDC1 Q96MU7 1/20 0.37
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
TAS2R14 Q9NYV8 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
GRIN2B Q13224 1/20 0.34
RAB9A P51151 1/20 0.34
PKM P14618 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MLYCD O95822 1/20 0.34
DPP4 P27487 1/20 0.34
DPP9 Q86TI2 1/20 0.34
DPP7 Q9UHL4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1461945 0.85 GRIN2B (0.48) SLC6A2SLC6A4LTA4HNR1H2NR1H3
SCHEMBL1460723 0.83 DRD2 (0.47) SLC6A2SLC6A4NR1H2NR1H3MEN1
SCHEMBL5370707 0.80 NR1H2 (0.40) SLC6A2SLC6A4NR1H2NR1H3MEN1
SCHEMBL1461003 0.79 SLC6A2 (0.41) SLC6A2SLC6A4OPRM1OPRD1OPRK1
SCHEMBL5357408 0.77 SLC6A2 (0.39) SLC6A2SLC6A4LTA4HNR1H2NR1H3
SCHEMBL5614293 0.77 SLC6A2 (0.45) SLC6A2SLC6A4LTA4HYTHDC1OPRM1
SCHEMBL21222467 0.77 NR1H2 (0.43) SLC6A2SLC6A4NR1H2NR1H3YTHDC1
SCHEMBL21222468 0.77 NR1H2 (0.43) SLC6A2SLC6A4NR1H2NR1H3YTHDC1
SCHEMBL1460744 0.75 DPP4 (0.48) SLC6A2SLC6A4OPRM1DPP4DPP9
SCHEMBL1460765 0.75 AGER (0.43) OPRM1DPP4DPP9DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101087754-B Cyclohexane derivatives HOFFMANN LA ROCHE 2012-01-18 CN claimed
CN-101087754-A Novel cyclohexane derivatives HOFFMANN LA ROCHE (CH) 2007-12-12 CN claimed
US-7253282-B2 Hexafluoroisopropanol substituted cyclohexane derivatives HOFFMAN-LA ROCHE INC. (US) 2007-08-07 US claimed
US-20060135601-A1 Novel hexafluoroisopropanol substituted cyclohexane derivatives HOFFMANN-LA ROCHE INC. 2006-06-22 US claimed
CN-101087754-B Cyclohexane derivatives HOFFMANN LA ROCHE 2012-01-18 CN disclosed
CN-101087754-A Novel cyclohexane derivatives HOFFMANN LA ROCHE (CH) 2007-12-12 CN disclosed
EP-1831158-A1 NOVEL CYCLOHEXANE DERIVATIVES F. Hoffmann-Roche AG (CH) 2007-09-12 EP disclosed
US-7253282-B2 Hexafluoroisopropanol substituted cyclohexane derivatives HOFFMAN-LA ROCHE INC. (US) 2007-08-07 US disclosed
WO-2006066779-A1 NOVEL CYCLOHEXANE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2006-06-29 WO disclosed
US-20060135601-A1 Novel hexafluoroisopropanol substituted cyclohexane derivatives HOFFMANN-LA ROCHE INC. 2006-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135601-A1 Novel hexafluoroisopropanol substituted cyclohexane derivatives NR1H3, NR1H2, NR1I2 SLC6A2 3185/4885SLC6A4 2782/4885LTA4H 1184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.